logo
South Gyeongsang Province inks space tech deal with Finland's ICEYE

South Gyeongsang Province inks space tech deal with Finland's ICEYE

Korea Herald19-06-2025
South Gyeongsang Province has signed an investment and business cooperation agreement with ICEYE, a Finnish global leader in synthetic aperture radar technology for small satellites, the province announced Thursday.
The agreement was formalized on Monday in Copenhagen, Denmark, during a visit by a delegation from the province led by Governor Park Wan-soo. South Gyeongsang Province is home to the nation's newly established space agency, the Korea AeroSpace Administration.
The partnership aims to support the province's growing aerospace industry by integrating ICEYE's advanced satellite capabilities. ICEYE operates the world's largest fleet of SAR satellites, which provide high-resolution Earth observation data — up to 25 centimeters — regardless of weather or lighting conditions. To date, the company has launched 48 satellites for both internal and client missions.
SAR technology, which uses radar to capture images of the Earth's surface, is effective for observation at night or through cloud cover. It is used across a range of sectors, including disaster monitoring, national defense and environmental surveillance.
Under the agreement, the two parties plan to explore joint initiatives such as partnerships with local companies, expanded use of satellite constellations, promotion of the satellite data industry and development of related talent.
'South Gyeongsang Province is the center of South Korea's aerospace industry, ranking first nationally, and this agreement with ICEYE will serve as a turning point for expanding our aerospace industry into the global market,' Governor Park said. 'The province will provide full support to ensure successful cooperation between the two parties.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Korea to invest W700b in advanced air vehicles through 2031
Korea to invest W700b in advanced air vehicles through 2031

Korea Herald

time3 days ago

  • Korea Herald

Korea to invest W700b in advanced air vehicles through 2031

Korea has decided to commit 700 billion won ($506 million) to securing domestically developed advanced air vehicles, or AAV, from 2027 to 2031, the Korea AeroSpace Administration said Thursday, aiming to commercialize the aircraft for both civilian and military use. Under the five-year AAV development plan, KASA expects to conduct pilot flights in 2030, followed by demonstrations for maritime transport and public safety missions in 2031. Certification processes for military and private sector use will be carried out in parallel, ensuring the aircraft can enter commercial service immediately after demonstrations. KASA said AAVs could cut travel time between Korea's islands and the mainland to about one hour, improving mobility for island residents and supporting maritime surveillance missions against pollution and illegal fishing. The aircraft will also be tested for emergency medical transport and deliveries of urgent supplies to remote island areas, bolstering regional development efforts. As Korea has one of the world's top 15 aerospace industries, KASA pointed out that securing a homemade aircraft platform is a key factor in nurturing its aerospace sector into a high-value-added industry. On the same day, KASA held a public hearing for the five-year AAV development plan in Daejeon with about 100 stakeholders from relevant government bodies, companies, academic and research institutions as well as local governments. Expert panels at the hearing noted that Korea can enter the new AAV market with high growth potential as the country can utilize its competitiveness in manufacturing key AAV technologies such as secondary batteries and semiconductors. According to Morgan Stanley, AAVs and related service markets are projected to reach $1 trillion by 2040. With features such as low noise, eco-friendliness and vertical takeoff and landing, AAVs are considered the future of mobility as they can quickly transport passengers and goods in the air within cities and between regions. 'Because the AAV market will undergo drastic change, integrating a range of technological sectors and impacting our daily lives in the future, it is important that the industry and government join hands to swiftly pursue the project and secure the lead in the market,' said Kim Hyun-dae, director general of KASA's Aeronautics Innovation Mission Directorate.

Innometry swings to profit in Q2
Innometry swings to profit in Q2

Korea Herald

time3 days ago

  • Korea Herald

Innometry swings to profit in Q2

Innometry, a Korean maker of X-ray inspection solutions, said Thursday its operating profit and net income returned to profitability in the second quarter, driven by new projects and cost-cutting measures. Operating profit reached 1 billion won ($723,000) and net income 600 million won, reversing losses from the first quarter. Revenue rose 22 percent from the previous quarter to 10.6 billion won. The company stated that while it remained in the red for the first half of the year, it has now fully recovered from a temporary stagnation in electric vehicle demand and the fallout from Swedish EV battery-maker Northvolt's bankruptcy, with the second quarter showing great improvement in performance. 'The cost-saving efforts we've pursued since last year, including management innovation and process optimization, have now yielded visible results,' said Hwang Jin-chul, executive vice president and head of the management support division at Innometry. 'We expect even stronger momentum in the second half, with increased orders from major domestic clients and new customers in China, as well as gains from new business initiatives.' Innometry develops non-destructive inspection equipment that uses X-ray CT technology to detect internal defects in secondary batteries without damaging the product. The company supplies inspection systems to mass production lines of Korea's top three battery-makers and other global cell manufacturers. 'The secondary battery industry is undergoing a restructure, but Innometry is strengthening its market position through strict quality, cost and delivery management,' said Lee Gap-soo, CEO of Innometry. He added that Innometry expects stronger results in the second half of the year, boosted by new Chinese orders and expansion into Through Glass Via substrates, smartphones and defense.

Daewoong's weekly weight-loss patch hits record absorption in human trial
Daewoong's weekly weight-loss patch hits record absorption in human trial

Korea Herald

time4 days ago

  • Korea Herald

Daewoong's weekly weight-loss patch hits record absorption in human trial

Daewoong Pharmaceutical and Daewoong Therapeutics said Wednesday their proprietary semaglutide microneedle patch achieved over 80 percent bioavailability compared to injectables, in a pilot pharmacokinetic study on humans. The study, the first human trial of its kind, applied Daewoong Therapeutics' proprietary drug delivery platform, Clopam, to a semaglutide microneedle patch. With 70 healthy adults, the trial compared the blood concentration of semaglutide delivered via the patch to that of a subcutaneous injection, adjusting for dosage differences. While existing microneedle patches with the same ingredient have shown about 30 percent bioavailability, Daewoong's patch demonstrated more than 80 percent -- the highest achievability among similar products -- and around 160 times higher absorption than oral semaglutide tablets. The results also indicated that the patch can maintain stable blood concentration for a week, enabling a weekly, high-dose formulation. According to Grand View Research, the global weight loss medication market is valued at $15.9 billion and is projected to reach $60.5 billion by 2030. Industry experts say that drug delivery technologies offering higher bioavailability and improved patient convenience will be a key factor in shaping the market. Microneedle patch technology, which addresses the limitations of both painful injections and low-efficiency oral drugs, is seen as a potential game changer. Additionally, it also has the advantage of higher cost efficiency, and stability, compared to other methods which require cold temperatures for storage. 'This study proves our ability to deliver a high dose of semaglutide via a single weekly patch — a breakthrough beyond current obesity treatment patches,' said Kang Bok-ki, CEO of Daewoong Therapeutics. 'It's a major step toward global licensing and commercialization.' Daewoong Pharmaceutical CEO Park Seong-soo added, 'Overcoming the high-dose delivery barrier marks a significant milestone. We will expand microneedle applications to other biologics and lead the global platform market.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store